Seroprevalence to adeno-associated virus type 6 in people with hemophilia B from a UK adult cohort.

Sara BoyceIzabela JamesSavita RangarajanNicola CurryCatherine N BagotSteven AustinMike LaffanSarah ManglesKandiah ChandrakumaranCarina Mundy

Published in: Research and practice in thrombosis and haemostasis (2022)

Based on limited data, there is no evidence of association between the presence of AAV6 neutralizing factors in people with hemophilia B and exposure to contaminated plasma derivatives. The frequency of AAV6 neutralizing factors in our hemophilia B cohort is similar to UK people with hemophilia A and non-hemophilia populations.

Keyphrases

gene therapy
dengue virus
risk assessment
big data
young adults
deep learning